Observational Study of Complications Related to Use of Peripherally Inserted Central Catheters (PRISM-1)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Adult patients necessitating insertion of a PICC for fluid, nutritional, chemotherapy or antibiotic treatment for a minimum of 14 days.
Male or Female Age > 18 years requiring central venous access
Ability to comply with study requirements
Written Informed Consent
Previous enrollment in study
Current or recent upper extremity thrombosis, occlusion or stenosis
Previous axillary lymph node dissection
Skin inflammatory condition or rashes within 15 cm from insertion site
Pre-existing history of hypercoagulability unrelated to malignant disease
Participating in trial involving antithrombotic, anticoagulant or anti- infective drug therapies
Positive blood culture within 48 hours from planned PICC placement
Known, renal insufficiency with chronic creatinine levels > 1.7 mg/dl